Studies have confirmed that GLUT inhibitors can induce disulfur status and cell death in cancer cells with high SLC7A11 expression, and cancer cell disulfidptosis may be a key factor in the therapeutic effect of GLUT inhibitors in the treatment of tumors with high SLC7A11 expression [86]. This evidence concerns the gene SLC2A1 and cancer.